Join the DDA or

Tillomed labetalol recall

Incorrect foil information

July 11th 2023

Tagged: MHRA alert


Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets due to an error on the foil blister packaging.

The affected batch is

Batch numberExpiry datePack sizeFirst distributed
22134508/202556 (4×14)15/05/2023

 The incorrect aluminium foil blister packaging states Labetalol 100mg tablets. The error is restricted to the foil; the description on the carton of a strength of ‘Labetalol 200mg tablets’ and the actual tablet contained in the blister are the correct 200mg tablet strength.

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Patients are advised that if the prescription was written within six months, the dispensary will make a resupply, otherwise patients should speak to their GP about a new prescription.

For all medical enquiries, please contact medical information at Tillomed Laboratories Limited by email to [email protected] or [email protected] or by telephone +44 (0)1480 402 400